K Jamerson, MA Weber, GL Bakris… - … England Journal of …, 2008 - Mass Medical Soc
Background The optimal combination drug therapy for hypertension is not established, although current US guidelines recommend inclusion of a diuretic. We hypothesized that …
G Bakris, A Briasoulis, B Dahlof, K Jamerson… - The American journal of …, 2013 - Elsevier
Combination therapy with benazepril 40 mg and amlodipine 10 mg (B+ A) has been shown to be more effective than benazepril 40 mg and hydrochlorothiazide (HCTZ) 25 mg (B+ H) in …
MJ Sorrentino - Current cardiology reports, 2011 - Springer
Aims: The ACCOMPLISH trial compared the rates of morbidity and mortality from cardiovascular causes when two different combination therapies were used in patients with …
DL Cohen, RR Townsend - The Journal of Clinical Hypertension, 2009 - ncbi.nlm.nih.gov
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) recommended using a thiazide diuretic as …
The article discusses a study of the use of benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, published in a 2008 issue of the" …
SG Chrysant, GL Bakris - American journal of hypertension, 2004 - academic.oup.com
Background: Most patients with hypertension require two or more antihypertensive medications to achieve blood pressure (BP) goals. This double-blind study compared the …
KA Jamerson - The FASEB Journal, 2010 - Wiley Online Library
Background ACCOMPLISH is the first trial to use combination therapy for the initial treatment of high‐risk hypertensive patients. The single hypothesis, the combination of …
Summary Background The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial …
ACCOMPLISH is the first trial designed to compare the effects on major fatal and non‐fatal cardiovascular endpoints of two forms of antihypertensive combination therapy: benazepril …